(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(butylsulfanyl)methyl]pyrrolidin-3-ol
Star0
Identification
- Generic Name
- (3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(butylsulfanyl)methyl]pyrrolidin-3-ol
- DrugBank Accession Number
- DB07463
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 335.468
Monoisotopic: 335.177981137 - Chemical Formula
- C16H25N5OS
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism U5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase Not Available Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961) - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as pyrrolopyrimidines. These are compounds containing a pyrrolopyrimidine moiety, which consists of a pyrrole ring fused to a pyrimidine. Pyrrole is 5-membered ring consisting of four carbon atoms and one nitrogen atom. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Pyrrolopyrimidines
- Sub Class
- Not Available
- Direct Parent
- Pyrrolopyrimidines
- Alternative Parents
- Aralkylamines / Aminopyrimidines and derivatives / Substituted pyrroles / N-alkylpyrrolidines / Imidolactams / Heteroaromatic compounds / Trialkylamines / Secondary alcohols / 1,2-aminoalcohols / Sulfenyl compounds show 5 more
- Substituents
- 1,2-aminoalcohol / Alcohol / Amine / Aminopyrimidine / Aralkylamine / Aromatic heteropolycyclic compound / Azacycle / Dialkylthioether / Heteroaromatic compound / Hydrocarbon derivative show 19 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- LTSUEVPGSXUJHT-OLZOCXBDSA-N
- InChI
- InChI=1S/C16H25N5OS/c1-2-3-4-23-9-12-7-21(8-13(12)22)6-11-5-18-15-14(11)19-10-20-16(15)17/h5,10,12-13,18,22H,2-4,6-9H2,1H3,(H2,17,19,20)/t12-,13+/m1/s1
- IUPAC Name
- (3R,4S)-1-({4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl}methyl)-4-[(butylsulfanyl)methyl]pyrrolidin-3-ol
- SMILES
- [H][C@]1(O)CN(CC2=CNC3=C2N=CN=C3N)C[C@]1([H])CSCCCC
References
- General References
- Not Available
- External Links
- PubChem Compound
- 11393519
- PubChem Substance
- 99443934
- ChemSpider
- 9568421
- BindingDB
- 36436
- ChEMBL
- CHEMBL1231347
- ZINC
- ZINC000013648011
- PDBe Ligand
- BIG
- PDB Entries
- 3dp9 / 4f3c / 4ffs / 4wkc / 5tc5 / 6ayr
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.0861 mg/mL ALOGPS logP 1.67 ALOGPS logP 1.66 Chemaxon logS -3.6 ALOGPS pKa (Strongest Acidic) 13.47 Chemaxon pKa (Strongest Basic) 8.37 Chemaxon Physiological Charge 1 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 91.06 Å2 Chemaxon Rotatable Bond Count 7 Chemaxon Refractivity 96.44 m3·mol-1 Chemaxon Polarizability 37.74 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule Yes Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.997 Blood Brain Barrier + 0.63 Caco-2 permeable - 0.6034 P-glycoprotein substrate Substrate 0.8295 P-glycoprotein inhibitor I Non-inhibitor 0.8971 P-glycoprotein inhibitor II Non-inhibitor 0.9341 Renal organic cation transporter Non-inhibitor 0.8069 CYP450 2C9 substrate Non-substrate 0.8472 CYP450 2D6 substrate Non-substrate 0.7284 CYP450 3A4 substrate Non-substrate 0.6066 CYP450 1A2 substrate Non-inhibitor 0.7613 CYP450 2C9 inhibitor Non-inhibitor 0.879 CYP450 2D6 inhibitor Non-inhibitor 0.849 CYP450 2C19 inhibitor Non-inhibitor 0.8453 CYP450 3A4 inhibitor Non-inhibitor 0.9172 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9092 Ames test Non AMES toxic 0.6149 Carcinogenicity Non-carcinogens 0.923 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.5934 LD50, mol/kg Not applicable hERG inhibition (predictor I) Strong inhibitor 0.5292 hERG inhibition (predictor II) Non-inhibitor 0.6261
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-000i-0039000000-cddabf79bae5f42b8036 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-001i-0109000000-f8c621d18ced3d8ce4b8 Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-00nr-0196000000-ab1467529aa175e5fa94 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-0gx0-1096000000-ace1a15489a9e3754ffd Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-000j-2961000000-5e5a375eee17ed9c2abd Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-0006-8491000000-ac22db3f0b50bf63e26f Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 176.38693 predictedDeepCCS 1.0 (2019) [M+H]+ 178.90694 predictedDeepCCS 1.0 (2019) [M+Na]+ 186.14442 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
- Kind
- Protein
- Organism
- Vibrio cholerae serotype O1 (strain ATCC 39315 / El Tor Inaba N16961)
- Pharmacological action
- Unknown
- General Function
- Methylthioadenosine nucleosidase activity
- Specific Function
- Catalyzes the irreversible cleavage of the glycosidic bond in both 5'-methylthioadenosine (MTA) and S-adenosylhomocysteine (SAH/AdoHcy) to adenine and the corresponding thioribose, 5'-methylthiorib...
- Gene Name
- mtnN
- Uniprot ID
- Q9KPI8
- Uniprot Name
- 5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase
- Molecular Weight
- 24525.01 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at September 15, 2010 21:22 / Updated at June 12, 2020 16:52